Icon

MITOZYTREX (nda050763)- (5MG/VIAL)

MITOMYCIN SUPERGEN
5MG/VIAL
No Yes
Expired Expired
None None
None No
Mitozytrex is not recommended as single-agent, primary therapy. Mitomycin has been shown to be useful in the therapy of disseminated adenocarcinoma of the stomach or pancreas in proven combinations with other approved chemotherapeutic agents and as palliative treatment when other modalities have failed. Mitozytrex is not recommended to replace appropriate surgery and/or radiotherapy.
0 0 0
Total Other Developers None
Drugs with Suitability No
5MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.